Bioceres Crop Solutions Corp (BIOX) reported Q3 2026 results showing a steep decline in sales and gross profit while certain profitability metrics improved.
Key highlights:
Cash flow and costs:
Balance sheet and market context:
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
Bioceres Crop Solutions CORP Hedge Fund Activity
We have seen 17 institutional investors add shares of Bioceres Crop Solutions CORP stock to their portfolio, and 17 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BALLAST ASSET MANAGEMENT, LP removed 745,030 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $975,989
- GAM HOLDING AG added 500,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $655,000
- ARDSLEY ADVISORY PARTNERS LP added 415,000 shares (+691.7%) to their portfolio in Q4 2025, for an estimated $543,650
- MARSHALL WACE, LLP added 382,744 shares (+180.0%) to their portfolio in Q4 2025, for an estimated $501,394
- FOURTH SAIL CAPITAL LP removed 296,573 shares (-6.4%) from their portfolio in Q4 2025, for an estimated $388,510
- UBS GROUP AG added 263,634 shares (+278.9%) to their portfolio in Q1 2026, for an estimated $117,290
- MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. added 224,225 shares (+29.8%) to their portfolio in Q4 2025, for an estimated $293,734
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
